Cell and gene therapy advocates believe they can make the case that the products are a good fit with the incoming Trump Administration’s health care vision.
Cell And Gene Therapy Field Sees Opportunity Under Trump
The cell and gene therapy field has reached an inflection point in the US as the second Trump Administration begins and advocates argue the sector could fit well with the “MAHA” agenda.
